A new study reveals high discontinuation rates of semaglutide among older adults with diabetes in the US and Japan, potentially limiting its cardioprotective benefits.
Despite advancements in guideline-directed therapy, heart failure readmissions remain high. At the American College of Physicians Internal Medicine Meeting 2025, Shudhanshu Alishetti, MD, outlined how...
In a large, matched-cohort study, patients with coronary artery disease receiving colchicine plus an SGLT2 inhibitor had significantly lower risks of mortality, MACE, ischemic stroke, and atrial...
A study presented at the American College of Cardiology's 74th Annual Scientific Session found that GLP-1RA use in patients with psoriasis was linked to a lower incidence of major adverse cardiovascular...
A new analysis found no difference in cardiovascular event rates between immediate and deferred antiretroviral therapy initiation among adults with HIV who had high CD4+ counts and low baseline...
Researchers set out to determine the prevalence of pickleball-related fractures examined in United States emergency departments from 2002 to 2022, as well the demographics associated with those fractures....
A retrospective cohort study suggested that colchicine prophylaxis at urate-lowering therapy initiation may lower cardiovascular event risk in patients with gout.
A study assesses whether the dual sodium–glucose co-transporter (SGLT) 1/2 inhibitor sotagliflozin reduces ischemic events in diabetes and kidney disease.
